Elevated plasma dityrosine in patients with hyperlipidemia compared to healthy individuals

Annals of Nutrition and Metabolism

Volumn 66, Issue 1, 2014, Pages 44-50

  Wu, Gui Rong ^a   Cheserek, Maureen ^a,b   Shi, Yong Hui ^a   Shen, Li Ye ^a   Yu, Jing ^a   Le, Guo Wei ^a  

^a JIANGNAN UNIVERSITY   (China)

^b EGERTON UNIVERSITY   (Kenya)

Author keywords

Atherosclerosis; Dityrosine; Dyslipidemia; Fluorescence spectrophotometry; Oxidative stress

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; CHOLESTEROL; DITYROSINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN; TYROSINE;

ADULT; AGE; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; SPECTROFLUOROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; MIDDLE AGED;

ADULT; ADVANCED OXIDATION PROTEIN PRODUCTS; BIOLOGICAL MARKERS; CHOLESTEROL; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; SPECTROMETRY, FLUORESCENCE; TRIGLYCERIDES; TYROSINE;

EID: 84923032709     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000365731     Document Type: Article

References (30)

1. Cantor RM, de Bruin T, Kono N, et al: Quantitative trait loci for apolipoprotein B, cholesterol, and triglycerides in familial combined hyperlipidemia pedigrees. Arterioscler Thromb Vasc Biol 2004; 10: 1935-1941
2. Ceriello A, Motz E: Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? the common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24: 816-823
3. Stocker R, Keaney JF: Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381-1478
4. Ayilavarapu S, Kantarci A, Fredman G, et al: Diabetes-induced oxidative stress is mediated by Ca 2+ -independent phospholipase A2 in neutrophils. J Immunol 2010; 184: 1507-1515
5. Touyz RM, Briones AM: Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens Res 2011; 34: 5-14
6. Jomova K, Vondrakova D, Lawson M, et al: Metalsoxidative stress and neurodegenerative disorders. Mol Cell Biochem 2010; 345: 91-104
7. DiMarco T, Giulivi C: Current analytical methods for the detection of dityrosine, a biomarker of oxidative stress, in biological samples. Mass Spectrom Rev 2007; 26: 108-120
8. Feeney MB, Schoneich C: Tyrosine modifications in aging. Antioxid Redox Signal 2012; 17: 1571-1579
9. Dunlop RA, Brunk UT, Rodgers KJ: Oxidized proteins: mechanisms of removal and consequences of accumulation. IUBMB life 2009; 61: 522-527
10. Leeuwenburgh C, Rasmussen JE, Hsu FF, et al: Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem 1997; 272: 3520-3526
11. Onody A, Csonka C, Giricz Z, et al: Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovasc Res 2003; 58: 663-670
12. Kuo DC, Hsu SP, Chien CT: Partially hydrolyzed guar gum supplement reduces high-fat diet increased blood lipids and oxidative stress and ameliorates FeCl 3 -induced acute arterial injury in hamsters. J Biomed Sci 2009; 16: 15
13. Malencik DA, Sprouse JF, Swanson CA, et al: Dityrosine: preparation, isolation, and analysis. Anal Biochem 1996; 242: 202-213
14. Korkmaz GG, Altinoglu E, Civelek S, et al: The association of oxidative stress markers with conventional risk factors in the metabolic syndrome. Metabolism 2013; 62: 828-835
15. Martinez-Hervas S, Fandos M, Real JT, et al: Insulin resistance and oxidative stress in familial combined hyperlipidemia. Atherosclerosis 2008; 199: 384-389
16. Ueno Y, Horio F, Uchida K, et al: Increase in oxidative stress in kidneys of diabetic Akita mice. Biosci Biotechnol Biochem 2002; 66: 869-872
17. Li H, Horke S, Forstermann U: Oxidative stress in vascular disease and its pharmacological prevention. Trends Pharmacol Sci 2013; 34: 313-319
18. Stinefelt B, Leonard SS, Blemings KP, et al: Free radical scavenging, DNA protection, and inhibition of lipid peroxidation mediated by uric acid. Ann Clin Lab Sci 2005; 35: 37-45
19. Poss J, Custodis F, Werner C, et al: Cardiovascular disease and dyslipidemia: beyond LDL. Curr Pharm Des 2011; 17: 861-870
20. Perugini C, Bagnati M, Cau C, et al: Distribution of lipid-soluble antioxidants in lipoproteins from healthy subjects. 1. Correlation with plasma antioxidant levels and composition of lipoproteins. Pharmacol Res 2000; 41: 55-65
21. Mollnau H, Schulz E, Daiber A, et al: Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells. Arterioscler Thromb Vasc Biol 2003; 23: 615-621
22. Augustyniak A, Stankiewicz A, Skrzydlewska E: The influence of L-carnitine on oxidative modification of LDL in vitro. Toxicol Mech Methods 2008; 18: 455-462
23. Doroszko A, Andrzejak R, Szuba A: Role of the nitric oxide metabolic pathway and prostanoids in the pathogenesis of endothelial dysfunction and essential hypertension in young men. Hypertens Res 2011; 34: 79-86
24. Yang RL, Shi YH, Hao G, et al: Increasing oxidative stress with progressive hyperlipidemia in human: relation between malondialdehyde and atherogenic index. J Clin Biochem Nutr 2008; 43: 154-158
25. Sun J, Sugiyama A, Masuda A, et al: Expressions of protein oxidation markers, dityrosine and advanced oxidation protein products in acetaminophen-induced liver injury in rats. J Vet Med Sci 2011; 73: 1185-1190
26. Venturini D, Simao ANC, Scripes NA, et al: Evaluation of oxidative stress in overweight subjects with or without metabolic syndrome. Obesity 2012; 20: 2361-2366
27. Korkmaz GG, Altinoglu E, Civelek S, et al: The association of oxidative stress markers with conventional risk factors in the metabolic syndrome. Metabolism 2013; 62: 828-835
28. Marsche G, Frank S, Hrzenjak A, et al: Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res 2009; 104: 750-757
29. Upston JM, Niu X, Brown AJ, et al: Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am J Pathol 2002; 160: 701-710
30. Polidori MC, Mattioli P, Aldred S, et al: Plasma antioxidant status, immunoglobulin G oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dement Geriatr Cogn Disord 2004; 18: 265-270